T John Curnutte

Affiliations

  • Director at Pliant Therapeutics Inc. (PLRX), 2025-06-10
  • at Orchard Therapeutics Plc (ORTX), 2024-01-24
  • Evp R&D at Portola Pharmaceuticals Inc (PTLA), 2019-05-22
  • Director at Diadexus Inc. (DDXS), 2015-07-16
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PTLA $65.00 10,000 $650,000.00 0 2017-07-18 Filing
PTLA $60.00 10,000 $600,000.00 0 2017-06-26 Filing
PTLA $59.33 3,802 $225,572.66 10,000 2017-06-26 Filing
PTLA $58.35 17,954 $1,047,615.90 13,802 2017-06-26 Filing
PTLA $57.24 10,729 $614,127.96 31,756 2017-06-26 Filing